Making Sense of Novartis and GlaxoSmithKline's Web of Deals

Now watching

Next video starts in : 7 Play

Making Sense of Novartis and GlaxoSmithKline's Web of Deals

Making Sense of Novartis and GlaxoSmithKline's Web of Deals
Replay video
Up next

Community Episode 12: Wedding Videography

Unlock your personal NFL Now stream by signing in to NFL.com

Making Sense of Novartis and GlaxoSmithKline's Web of Deals

by TheStreet.com Videos 1:26 mins

Making Sense of Novartis and GlaxoSmithKline's Web of Deals

by TheStreet.com Videos 1:26 mins

The pharmaceutical industry had a deluge of M&A activity on Tuesday as heavyweights Novartis and GlaxoSmithKline announced they were trading $20 billion worth of assets. Novartis will purchase GSK's oncology portfolio for $14.5 billion, strengthening its number two spot in the specialty. Meanwhile, GSK will purchase Novartis' vaccines unit for $5.25 billion. The two companies will also form a separate consumer healthcare business in which GSK will hold a 63.5% majority stake.

Must Watch

Community

  1. 27:26

    Community Episode 1: Ladders

  2. 27:26

    Community Episode 2: Lawnmower Maintenance and Postnatal Care

  3. 24:40

    Community Episode 3: Basic Crisis Room Decorum

  4. 30:58

    Community Episode 4: Queer Studies and Advanced Waxing

  5. 28:45

    Community Episode 5: Laws of Robotics and Party Rights

  6. 28:13

    Community Episode 6: Basic Email Security

Other Space

  1. 27:05

    Other Space Episode 1: Into the Great Beyond...Beyond

  2. 25:20

    Other Space Episode 2: Getting to Know You

  3. 25:51

    Other Space Episode 3: The Death of A.R.T.

  4. 25:46

    Other Space Episode 4: Ted Talks

  5. 26:44

    Other Space Episode 5: Trouble's Brewing

  6. 27:02

    Other Space Episode 6: Powerless